Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2026 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy
|FCC Public Files

Back to Press Play with Madeleine Brand

Press Play with Madeleine Brand

Boosters and rapid COVID tests aren’t available. US government needs to step up on pandemic, says columnist

“The fact is that for most of us, the data suggests that we still got lots of strong protection, especially against serious disease. So rushing headlong to get a booster … it may just be the result of panic rather than science,” says Carl Zimmer, author of the “Matter” column for the New York Times.

  • rss
  • Share
By Madeleine Brand • Sep 21, 2021 • 8m Listen

Johnson & Johnson has released new research showing that a second dose of its vaccine increases protection against COVID-19. The company has since submitted its data to the FDA. What does this mean for Americans wanting booster shots?

“The fact is that for most of us, the data suggests that we still got lots of strong protection, especially against serious disease. So rushing headlong to get a booster … it may just be the result of panic rather than science,” says Carl Zimmer, author of the “Matter” column for the New York Times.

Meanwhile, the U.S. has shelved one of its most effective tools to stop the spread of coronavirus: regular rapid testing.

“We should all have really cheap or maybe free tests that we can be taking regularly. That could be a huge factor combined with things like masks and vaccines to really get this pandemic under control. But when a test is like $20 … people aren't going to be doing it every few days, like some think we should do.”

Zimmer says the government hasn’t taken enough leadership on this. “There could potentially be things that the government could do to boost that supply, maybe … cut through some of the red tape for getting other devices approved. And really, set up programs so that we can … just get the things in the mail, how about that?”

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Madeleine Brand

    Host, 'Press Play'

  • KCRW placeholder

    Sarah Sweeney

    Vice President of Talk Programming, KCRW

  • KCRW placeholder

    Angie Perrin

    Producer, Press Play

  • KCRW placeholder

    Michell Eloy

    Line Editor, Press Play

  • KCRW placeholder

    Carl Zimmer

    author of the “Matter” column for the New York Times

    NewsCoronavirusNationalHealth & Wellness
Back to Press Play with Madeleine Brand